Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction

Journal of Cellular and Molecular Medicine

Volumn 15, Issue 5, 2011, Pages 1032-1043

  Wen, Zhuzhi ^a   Zheng, Shaoxin ^a   Zhou, Changqing ^a   Wang, Jingfeng ^a   Wang, Tong ^a  

^a SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Bone marrow; Mesenchymal stem cells; Myocardial infarction; Repair mechanisms

Indexed keywords

CYTOKINE;

ANGIOGENESIS; ANIMAL; BONE MARROW; CYTOLOGY; HEART INFARCTION; HUMAN; MESENCHYMAL STEM CELL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; REGENERATION; REVIEW;

ANIMALS; BONE MARROW; CYTOKINES; HUMANS; MESENCHYMAL STEM CELLS; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; REGENERATION;

ANIMALIA;

EID: 79957582277     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01255.x     Document Type: Review

References (100)

1. Gaziano TA. Cardiovascular disease in the developing world and its cost-effective management. Circulation. 2005; 112: 3547-53.
2. Mollmann H, Nef H, Elsasser A, et al Stem cells in myocardial infarction: from bench to bedside. Heart. 2009; 95: 508-14.
3. Oettgen P, Boyle AJ, Schulman SP, et al Cardiac stem cell therapy. Need for optimization of efficacy and safety monitoring. Circulation. 2006; 114: 353-8.
4. Makino S, Fukuda K, Miyoshi S, et al Cardiomyocytes can be generated from marrow stromal cellsin vitro. J Clin Invest. 1999; 103: 697-705.
5. Liechty KW, MacKenzie TC, Shaaban AF, et al Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med. 2000; 6: 1282-6.
6. Pittenger MF, Mackay AM, Beck SC, et al Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284: 143-7.
7. Wang T, Tang W, Sun S, et al Mesenchymal stem cells improve outcomes of cardiopulmonary resuscitation in myocardial infarcted rats. J Mol Cell Cardiol. 2009; 46: 378-84.
8. Wang T, Tang W, Sun S, et al Improved outcomes of cardiopulmonary resuscitation in rats with myocardial infarction treated with allogenic bone marrow mesenchymal stem cells. Crit Care Med. 2009; 37: 833-9.
9. Gersh BJ, Simari RD, Behfar A, et al Cardiac cell repair therapy: a clinical perspective. Mayo Clin Proc. 2009; 84: 876-92.
10. Orlic D, Kajstura J, Chimenti S, et al Bone marrow cells regenerate infarcted myocardium. Nature. 2001; 410: 701-5.
11. Wang T, Xu Z, Jiang W, et al Cell-to-cell contact induces mesenchymal stem cell to differentiate into cardiomyocyte and smooth muscle cell. Int J Cardiol. 2006; 109: 74-81.
12. Piao H, Youn TJ, Kwon JS, et al Effects of bone marrow derived mesenchymal stem cells transplantation in acutely infarcting myocardium. Eur J Heart Fail. 2005; 7: 730-8.
13. Jiang W, Ma A, Wang T, et al Homing and differentiation of mesenchymal stem cells delivered intravenously to ischemic myocardiumin vivo: a time-series study. Pflugers Arch. 2006; 453: 43-52.
14. Quevedo HC, Hatzistergos KE, Oskouei BN, et al Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathyviatrilineage differentiating capacity. Proc Natl Acad Sci USA. 2009; 106: 14022-7.
15. Fukuda K, Fujita J. Mesenchymal, but not hematopoietic, stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction in mice. Kidney Int. 2005; 68: 1940-3.
16. Berry MF, Engler AJ, Woo YJ, et al Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am J Physiol Heart Circ Physiol. 2006; 290: H2196-203.
17. Rose RA, Jiang H, Wang X, et al Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytesin vitro. Stem Cells. 2008; 26: 2884-92.
18. Silva GV, Litovsky S, Assad JA, et al Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation. 2005; 111: 150-6.
19. Grinnemo KH, Mansson-Broberg A, Leblanc K, et al Human mesenchymal stem cells do not differentiate into cardiomyocytes in a cardiac ischemic xenomodel. Ann Med. 2006; 38: 144-53.
20. Penna C, Raimondo S, Ronchi G, et al Early homing of adult mesenchymal stem cells in normal and infarcted isolated beating hearts. J Cell Mol Med. 2008; 12: 507-21.
21. Nagaya N, Fujii T, Iwase T, et al Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol. 2004; 287: H2670-6.
22. Li X, Yu X, Lin Q, et al Bone marrow mesenchymal stem cells differentiate into functional cardiac phenotypes by cardiac microenvironment. J Mol Cell Cardiol. 2007; 42: 295-303.
23. Chang SA, Lee EJ, Kang HJ, et al Impact of myocardial infarct proteins and oscillating pressure on the differentiation of mesenchymal stem cells: effect of acute myocardial infarction on stem cell differentiation. Stem Cells. 2008; 26: 1901-12.
24. Yang J, Zhou W, Zheng W, et al Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction. Cardiology. 2007; 107: 17-29.
25. Grauss RW, van Tuyn J, Steendijk P, et al Forced myocardin expression enhances the therapeutic effect of human mesenchymal stem cells after transplantation in ischemic mouse hearts. Stem Cells. 2008; 26: 1083-93.
26. Guo J, Lin G, Bao C, et al Insulin-like growth factor 1 improves the efficacy of mesenchymal stem cells transplantation in a rat model of myocardial infarction. J Biomed Sci. 2008; 15: 89-97.
27. Crisostomo PR, Wang Y, Markel TA, et al Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism. Am J Physiol Cell Physiol. 2008; 294: C675-82.
28. Dai W, Hale SL, Martin BJ, et al Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation. 2005; 112: 214-23.
29. Oswald J, Boxberger S, Jorgensen B, et al Mesenchymal stem cells can be differentiated into endothelial cellsin vitro. Stem Cells. 2004; 22: 377-84.
30. Yu J, Li M, Qu Z, et al SDF-1/CXCR4-mediated migration of transplanted bone marrow stromal cells toward areas of heart myocardial infarction through activation of PI3K/Akt. J Cardiovasc Pharmacol. 2010; 55: 496-505.
31. Tang J, Wang J, Yang J, et al Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats. Eur J Cardiothorac Surg. 2009; 36: 644-50.
32. Guo Y, He J, Wu J, et al Locally overexpressing hepatocyte growth factor prevents post-ischemic heart failure by inhibition of apoptosisviacalcineurin-mediated pathway and angiogenesis. Arch Med Res. 2008; 39: 179-88.
33. Matsumoto R, Omura T, Yoshiyama M, et al Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction. Arterioscler Thromb Vasc Biol. 2005; 25: 1168-73.
34. Enoki C, Otani H, Sato D, et al Enhanced mesenchymal cell engraftment by IGF-1 improves left ventricular function in rats undergoing myocardial infarction. Int J Cardiol. 2010; 138: 9-18.
35. Fan M, Chen W, Liu W, et al The effect of age on the efficacy of human mesenchymal stem cell transplantation after a myocardial infarction. Rejuvenation Res. 2010; 13: 429-38.
36. Trkov S, Eng G, Di Liddo R, et al Micropatterned three-dimensional hydrogel system to study human endothelial-mesenchymal stem cell interactions. J Tissue Eng Regen Med. 2010; 4: 205-15.
37. Gnecchi M, Zhang Z, Ni A, et al Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res. 2008; 103: 1204-19.
38. Kinnaird T, Stabile E, Burnett MS, et al Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promotein vitroandin vivoarteriogenesis through paracrine mechanisms. Circ Res. 2004; 94: 678-85.
39. Kajstura J, Rota M, Whang B, et al Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res. 2005; 96: 127-37.
40. Hashemi SM, Ghods S, Kolodgie FD, et al A placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction. Eur Heart J. 2008; 29: 251-9.
41. Noiseux N, Gnecchi M, Lopez-Ilasaca M, et al Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol Ther. 2006; 14: 840-50.
42. Gnecchi M, He H, Noiseux N, et al Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J. 2006; 20: 661-9.
43. Reinecke H, Minami E, Zhu WZ, et al Cardiogenic differentiation and transdifferentiation of progenitor cells. Circ Res. 2008; 103: 1058-71.
44. Mazhari R, Hare JM. Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche. Nat Clin Pract Cardiovasc Med. 2007; 4: S21-6.
45. Hatzistergos KE, Quevedo H, Oskouei BN, et al Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res. 2010: DOI:.
46. Tang J, Wang J, Kong X, et al Vascular endothelial growth factor promotes cardiac stem cell migrationviathe PI3K/Akt pathway. Exp Cell Res. 2009; 315: 3521-31.
47. Urbanek K, Rota M, Cascapera S, et al Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res. 2005; 97: 663-73.
48. Padin-Iruegas ME, Misao Y, Davis ME, et al Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction. Circulation. 2009; 120: 876-87.
49. Zisa D, Shabbir A, Suzuki G, et al Vascular endothelial growth factor (VEGF) as a key therapeutic trophic factor in bone marrow mesenchymal stem cell-mediated cardiac repair. Biochem Biophys Res Commun. 2009; 390: 834-8.
50. Lee BC, Hsu HC, Tseng WY, et al Cell therapy generates a favourable chemokine gradient for stem cell recruitment into the infarcted heart in rabbits. Eur J Heart Fail. 2009; 11: 238-45.
51. Zhao T, Zhang D, Millard RW, et al Stem cell homing and angiomyogenesis in transplanted hearts are enhanced by combined intramyocardial SDF-1alpha delivery and endogenous cytokine signaling. Am J Physiol Heart Circ Physiol. 2009; 296: H976-86.
52. Li TS, Hayashi M, Ito H, et al Regeneration of infarcted myocardium by intramyocardial implantation ofex vivotransforming growth factor-beta-preprogrammed bone marrow stem cells. Circulation. 2005; 111: 2438-45.
53. Tang YL, Zhao Q, Qin X, et al Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Ann Thorac Surg. 2005; 80: 229-36.
54. Sun H, Wang H, Hu S. Effects of estrogen on diverse stem cells and relevant intracellular mechanisms. Sci China Life Sci. 2010; 53: 542-7.
55. Iwakura A, Shastry S, Luedemann C, et al Estradiol enhances recovery after myocardial infarction by augmenting incorporation of bone marrow-derived endothelial progenitor cells into sites of ischemia-induced neovascularizationviaendothelial nitric oxide synthase-mediated activation of matrix metalloproteinase-9. Circulation. 2006; 113: 1605-14.
56. Johansson U, Rasmusson I, Niclou SP, et al Formation of composite endothelial cell-mesenchymal stem cell islets: a novel approach to promote islet revascularization. Diabetes. 2008; 57: 2393-401.
57. Beckermann BM, Kallifatidis G, Groth A, et al VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma. Br J Cancer. 2008; 99: 622-31.
58. Kasper G, Dankert N, Tuischer J, et al Mesenchymal stem cells regulate angiogenesis according to their mechanical environment. Stem Cells. 2007; 25: 903-10.
59. Yang ZJ, Ma DC, Wang W, et al Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantationvianoninfarct-relative artery in acute myocardial infarction. Gene Ther. 2006; 13: 1564-8.
60. Dufourcq P, Descamps B, Tojais NF, et al Secreted frizzled-related protein-1 enhances mesenchymal stem cell function in angiogenesis and contributes to neovessel maturation. Stem Cells. 2008; 26: 2991-3001.
61. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005; 105: 1815-22.
62. Bishopric NH. Mesenchymal stem cell-derived IL-10 and recovery from infarction: a third pitch for the chord. Circ Res. 2008; 103: 125-7.
63. Du YY, Zhou SH, Zhou T, et al Immuno-inflammatory regulation effect of mesenchymal stem cell transplantation in a rat model of myocardial infarction. Cytotherapy. 2008; 10: 469-78.
64. Zhang S, Lu S, Ge J, et al Increased heme oxygenase-1 expression in infarcted rat hearts following human bone marrow mesenchymal cell transplantation. Microvasc Res. 2005; 69: 64-70.
65. Zeng B, Chen H, Zhu C, et al Effects of combined mesenchymal stem cells and heme oxygenase-1 therapy on cardiac performance. Eur J Cardiothorac Surg. 2008; 34: 850-6.
66. Kelly ML, Wang M, Crisostomo PR, et al TNF receptor 2, NOT tnf receptor 1, enhances mesenchymal stem cell-mediated cardiac protection following acute ischemia. Shock. 2010; 33: 602-7.
67. Crisostomo PR, Wang M, Herring CM, et al Gender differences in injury induced mesenchymal stem cell apoptosis and VEGF, TNF, IL-6 expression: role of the 55 kDa TNF receptor (TNFR1). J Mol Cell Cardiol. 2007; 42: 142-9.
68. Hu X, Yu SP, Fraser JL, et al Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart functionviaenhanced survival of implanted cells and angiogenesis. J Thorac Cardiovasc Surg. 2008; 135: 799-808.
69. Li W, Ma N, Ong LL, et al Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells. 2007; 25: 2118-27.
70. Mirotsou M, Zhang Z, Deb A, et al Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc Natl Acad Sci USA. 2007; 104: 1643-8.
71. Wang X, Zhao T, Huang W, et al Hsp20-engineered mesenchymal stem cells are resistant to oxidative stressviaenhanced activation of Akt and increased secretion of growth factors. Stem Cells. 2009; 27: 3021-31.
72. Zhang M, Mal N, Kiedrowski M, et al SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. FASEB J. 2007; 21: 3197-207.
73. Hahn JY, Cho HJ, Kang HJ, et al Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction. J Am Coll Cardiol. 2008; 51: 933-43.
74. Yao Y, Zhang F, Wang L, et al Lipopolysaccharide preconditioning enhances the efficacy of mesenchymal stem cells transplantation in a rat model of acute myocardial infarction. J Biomed Sci. 2009; 16: 74.
75. Song SW, Chang W, Song BW, et al Integrin-linked kinase is required in hypoxic mesenchymal stem cells for strengthening cell adhesion to ischemic myocardium. Stem Cells. 2009; 27: 1358-65.
76. Wang D, Shen W, Zhang F, et al Connexin43 promotes survival of mesenchymal stem cells in ischaemic heart. Cell Biol Int. 2010; 34: 415-23.
77. Hu X, Dai S, Wu WJ, et al Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis. Circulation. 2007; 116: 654-63.
78. Ohnishi S, Sumiyoshi H, Kitamura S, et al Mesenchymal stem cells attenuate cardiac fibroblast proliferation and collagen synthesis through paracrine actions. FEBS Lett. 2007; 581: 3961-6.
79. Mias C, Lairez O, Trouche E, et al Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction. Stem Cells. 2009; 27: 2734-43.
80. Xu X, Xu Z, Xu Y, et al Effects of mesenchymal stem cell transplantation on extracellular matrix after myocardial infarction in rats. Coron Artery Dis. 2005; 16: 245-55.
81. Shu T, Zeng B, Ren X, et al HO-1 modified mesenchymal stem cells modulate MMPs/TIMPs system and adverse remodeling in infarcted myocardium. Tissue Cell. 2010; 42: 217-22.
82. Li L, Zhang S, Zhang Y, et al Paracrine action mediate the antifibrotic effect of transplanted mesenchymal stem cells in a rat model of global heart failure. Mol Biol Rep. 2009; 36: 725-31.
83. Jo J, Nagaya N, Miyahara Y, et al Transplantation of genetically engineered mesenchymal stem cells improves cardiac function in rats with myocardial infarction: benefit of a novel nonviral vector, cationized dextran. Tissue Eng. 2007; 13: 313-22.
84. Li Q, Turdi S, Thomas DP, et al Intra-myocardial delivery of mesenchymal stem cells ameliorates left ventricular and cardiomyocyte contractile dysfunction following myocardial infarction. Toxicol Lett. 2010; 195: 119-26.
85. Feygin J, Mansoor A, Eckman P, et al Functional and bioenergetic modulations in the infarct border zone following autologous mesenchymal stem cell transplantation. Am J Physiol Heart Circ Physiol. 2007; 293: H1772-80.
86. Boomsma RA, Swaminathan PD, Geenen DL. Intravenously injected mesenchymal stem cells home to viable myocardium after coronary occlusion and preserve systolic function without altering infarct size. Int J Cardiol. 2007; 122: 17-28.
87. Kumar A, Kumar A, Paladugu B, et al Transforming growth factor-beta1 blocksin vitrocardiac myocyte depression induced by tumor necrosis factor-alpha, interleukin-1beta, and human septic shock serum. Crit Care Med. 2007; 35: 358-64.
88. Nguyen BK, Maltais S, Perrault LP, et al Improved function and myocardial repair of infarcted heart by intracoronary injection of mesenchymal stem cell-derived growth factors. J Cardiovasc Transl Res. 2010; 3: 547-58.
89. Hu Q, Wang X, Lee J, et al Profound bioenergetic abnormalities in peri-infarct myocardial regions. Am J Physiol Heart Circ Physiol. 2006; 291: H648-57.
90. Gnecchi M, He H, Melo LG, et al Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction. Stem Cells. 2009; 27: 971-9.
91. Pak HN, Qayyum M, Kim DT, et al Mesenchymal stem cell injection induces cardiac nerve sprouting and increased tenascin expression in a Swine model of myocardial infarction. J Cardiovasc Electrophysiol. 2003; 14: 841-8.
92. Kim SK, Pak HN, Park JH, et al Cardiac cell therapy with mesenchymal stem cell induces cardiac nerve sprouting, angiogenesis, and reduced connexin43-positive gap junctions, but concomitant electrical pacing increases connexin43-positive gap junctions in canine heart. Cardiol Young. 2010; 20: 308-17.
93. Zhang L, Seitz LC, Abramczyk AM, et al cAMP initiates early phase neuron-like morphology changes and late phase neural differentiation in mesenchymal stem cells. Cell Mol Life Sci. 2010: DOI.
94. Macia E, Boyden PA. Stem cell therapy is proarrhythmic. Circulation. 2009; 119: 1814-23.
95. Ly HQ, Nattel S. Stem cells are not proarrhythmic: letting the genie out of the bottle. Circulation. 2009; 119: 1824-31.
96. Chang MG, Tung L, Sekar RB, et al Proarrhythmic potential of mesenchymal stem cell transplantation revealed in anin vitrococulture model. Circulation. 2006; 113: 1832-41.
97. Mohyeddin-Bonab M, Mohamad-Hassani MR, Alimoghaddam K, et al Autologousin vitroexpanded mesenchymal stem cell therapy for human old myocardial infarction. Arch Iran Med. 2007; 10: 467-73.
98. Chen SL, Fang WW, Ye F, et al Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol. 2004; 94: 92-5.
99. Mills WR, Mal N, Kiedrowski MJ, et al Stem cell therapy enhances electrical viability in myocardial infarction. J Mol Cell Cardiol. 2007; 42: 304-14.
100. Wang D, Zhang F, Shen W, et al Mesenchymal stem cell injection ameliorates the inducibility of ventricular arrhythmias after myocardial infarction in rats. Int J Cardiol. 2010: DOI:.